The tumor suppressor TIP30 (HTATIP2 or CC3) could inhibit lipid metabolism by the AKT/mTOR signaling pathway, decreasing the expression of SREBP1 and its target genes (SCD and FASN) and thus inhibiting the tumor growth of liver cells (Fig. 2).37 Here, SCD is linked to neoplasm.